Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lipitor

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lipitor was produced by Pfizer and Astellas.

Pfizer set to unveil Mylan merger and spin-off

Pfizer set to unveil Mylan merger and spin-off

Its biggest off-patent brands would include drugs such as Pfizer’s Lipitor, Viagra and Mylan’s Epipen.

The handover: Pfizer reshapes itself for a new era

The handover: Pfizer reshapes itself for a new era autonomous. Created in the summer reshuffle, the Established Medicines division includes the majority of Pfizer’s off-patent blockbuster pills, including Lyrica, Lipitor, Norvasc and Viagra, and a number of other

Pfizer names next CEO as Read retires

Pfizer names next CEO as Read retires Ian Read’s tenure has had plenty of ups and downs, and undoubtedly one of his biggest challenges was overcoming the patent expiry of its mega-blockbuster Lipitor in November 2011. ... Pfizer slipped down the rankings in the years following the loss of

Using social data to see patients more clearly

Using social data to see patients more clearly Drugs and databases analysed. The study focused on two drugs, aspirin and Lipitor, that had a relatively high prevalence among the ADR reports in both the clinical and the social media ... In both data sets, musculoskeletal pain and cramps were among the

Pharma set for a strong 2015 as drug sales jump

Pharma set for a strong 2015 as drug sales jump Pfizer was in fact the hardest hit, with its once $13bn a year statin Lipitor (atorvastatin) losing its patents in 2011/12, with sales falling by $10bn in just two years.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics